Large-scale testing (Phase 3)Ended earlyNCT02703272
What this trial is testing
A Safety and Efficacy Study of Ibrutinib in Pediatric and Young Adult Participants With Relapsed or Refractory Mature B-cell Non-Hodgkin Lymphoma
Who this might be right for
Lymphoma, Non-Hodgkin
Janssen Research & Development, LLC 72